Hydrodynamic Transfection of Hepatocytes for the Study of Hepatocellular Carcinogenesis
- 6 February 2024
- book chapter
- Published by Springer Nature
- Vol. 2769, 77-85
Abstract
Hydrodynamic tail vein injection (HTVi), also called hydrodynamic gene transfer (HGT), is attracting increasing interest for modeling hepatic carcinogenesis. This highly versatile approach reproducibly provides efficient in vivo transfection of hepatocytes with naked DNA. Here, we give an in-depth description of the injection procedure, which is key for the success of the method. HTVi requires the injection of a large volume of a solution containing plasmids into the tail vein of the mouse. The transient right heart overload created by the injection forces the blood to flow back into the hepatic veins, enlarging the endothelial fenestrae and permeabilizing a fraction of hepatocytes for a few seconds. This results in the uptake of plasmids by the permeabilized hepatocytes, giving rise to their in vivo transfection. Including the Sleeping Beauty transposon system among the injected plasmids leads to the stable transfection of a subset of hepatocytes. HTVi is a powerful technique which enables numerous applications in liver cancer biology, such as a study of oncogene cooperation, of tumor heterogeneity, and interaction with the tumor microenvironment. Key words In vivo transfection Hepatocytes Hydrodynamic gene delivery Mouse model Hepatocellular carcinomaKeywords
This publication has 27 references indexed in Scilit:
- Investigation of Oncogenic Cooperation in Simple Liver-Specific Transgenic Mouse Models Using Noninvasive In Vivo ImagingPLOS ONE, 2013
- Coactivation of AKT and β-Catenin in Mice Rapidly Induces Formation of Lipogenic Liver TumorsCancer Research, 2011
- Increased Lipogenesis, Induced by AKT-mTORC1-RPS6 Signaling, Promotes Development of Human Hepatocellular CarcinomaGastroenterology, 2011
- Bmi1 Functions as an Oncogene Independent of Ink4A/Arf Repression in Hepatic CarcinogenesisMolecular Cancer Research, 2009
- Role of Cyclin D1 as a Mediator of c-Met– and β-Catenin–Induced HepatocarcinogenesisCancer Research, 2008
- Experimental models of hepatocellular carcinomaJournal of Hepatology, 2008
- Integration of genomic analysis and in vivo transfection to identify sprouty 2 as a candidate tumor suppressor in liver cancer†Hepatology, 2007
- Distinct pathways of genomic progression to benign and malignant tumors of the liverProceedings of the National Academy of Sciences, 2007
- Phenotypic correction and long-term expression of factor VIII in hemophilic mice by immunotolerization and nonviral gene transfer using the Sleeping Beauty transposon systemBlood, 2005
- Expression of Naked Plasmid DNA Injected into the Afferent and Efferent Vessels of Rodent and Dog LiversHuman Gene Therapy, 1997